Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer

Fig. 1

Differential metabolites used to predict progression of GEC in the case-cohort study. A The case-cohort study design; B PLS-DA three-dimensional scores plot discriminating GEC cases and sub-cohort individuals; C Volcano plot showing correlations between FDR q value and FC for all metabolites in GEC cases and sub-cohort individuals; D ROC curves of prediction models to predict GEC formation; E Boxplots showing levels of differential metabolites in serum samples of GEC cases and sub-cohort individuals

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us